Mutagenicity testing with transgenic mice. Part II: Comparison with the mouse spot test
AUTOR(ES)
Wahnschaffe, Ulrich
FONTE
BioMed Central
RESUMO
The mouse spot test, an in vivo mutation assay, has been used to assess a number of chemicals. It is at present the only in vivo mammalian test system capable of detecting somatic gene mutations according to OECD guidelines (OECD guideline 484). It is however rather insensitive, animal consuming and expensive type of test. More recently several assays using transgenic animals have been developed. From data in the literature, the present study compares the results of in vivo testing of over twenty chemicals using the mouse spot test and compares them with results from the two transgenic mouse models with the best data base available, the lacI model (commercially available as the Big Blue® mouse), and the lacZ model (commercially available as the Muta™ Mouse). There was agreement in the results from the majority of substances. No differences were found in the predictability of the transgenic animal assays and the mouse spot test for carcinogenicity. However, from the limited data available, it seems that the transgenic mouse assay has several advantages over the mouse spot test and may be a suitable test system replacing the mouse spot test for detection of gene but not chromosome mutations in vivo.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=548508Documentos Relacionados
- Mutagenicity testing with transgenic mice. Part I: Comparison with the mouse bone marrow micronucleus test
- Analysis of the mouse protamine 1 promoter in transgenic mice.
- Part II: Detailed Analysis of the Data
- PART II: CHANGES IN HEAD SHAPE
- Glucocorticoid regulation of mouse mammary tumor virus sequences in transgenic mice.